306 related articles for article (PubMed ID: 11422473)
41. Helicobacter pylori anti-CagA antibodies: prevalence in symptomatic and asymptomatic subjects in Turkey.
Abasiyanik MF; Sander E; Salih BA
Can J Gastroenterol; 2002 Aug; 16(8):527-32. PubMed ID: 12226680
[TBL] [Abstract][Full Text] [Related]
42. CagA antibodies as a marker of virulence in chilean patients with Helicobacter pylori infection.
Harris PR; Godoy A; Arenillas S; Riera F; García D; Einisman H; Peña A; Rollán A; Duarte I; Guiraldes E; Perez-Perez G
J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):596-602. PubMed ID: 14581804
[TBL] [Abstract][Full Text] [Related]
43. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases.
Weel JF; van der Hulst RW; Gerrits Y; Roorda P; Feller M; Dankert J; Tytgat GN; van der Ende A
J Infect Dis; 1996 May; 173(5):1171-5. PubMed ID: 8627069
[TBL] [Abstract][Full Text] [Related]
44. [Helicobacter pylori genotypes and their association with host's immune response].
Garza-González E; Pérez-Pérez GI; Tijerina-Menchaca R; Maldonado-Garza HJ; Bosques-Padilla FJ
Rev Gastroenterol Mex; 2002; 67(3):155-60. PubMed ID: 12653051
[TBL] [Abstract][Full Text] [Related]
45. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
[TBL] [Abstract][Full Text] [Related]
46. Could gastric histology be a useful marker for making decision on Helicobacter pylori eradication therapy in patients with dyspepsia?
Arruda SM; Forones NM; Jucá NT; de Barros KS
Arq Gastroenterol; 2009; 46(3):209-13. PubMed ID: 19918688
[TBL] [Abstract][Full Text] [Related]
47. Specific Helicobacter pylori antigens unable to distinguish nonucler dyspepsia or peptic ulcer cases from asymptomatic seropositive controls: a nested case-control study in employees of a large company.
Schilling D; Ott MG; Nilius M; Köhler G; Zober A; Messerer P; Riemann JF
Dig Dis Sci; 2000 Dec; 45(12):2444-50. PubMed ID: 11258573
[TBL] [Abstract][Full Text] [Related]
48. Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia.
Zambon CF; Navaglia F; Basso D; Rugge M; Plebani M
J Clin Pathol; 2003 Apr; 56(4):287-91. PubMed ID: 12663641
[TBL] [Abstract][Full Text] [Related]
49. Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association.
Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
Arch Intern Med; 1995 Jan; 155(1):82-7. PubMed ID: 7802524
[TBL] [Abstract][Full Text] [Related]
50. Helicobacter pylori endemic and gastric disease.
Siavoshi F; Malekzadeh R; Daneshmand M; Ashktorab H
Dig Dis Sci; 2005 Nov; 50(11):2075-80. PubMed ID: 16240218
[TBL] [Abstract][Full Text] [Related]
51. Seropositivity against Helicobacter pylori CagA in Turkish gastric cancer patients.
Gürbüz AK; Ozel AM; Yazgan Y; Günay A; Ozdemir S; Demirtürk L; Emekdaş G
J Clin Gastroenterol; 2001; 33(5):389-92. PubMed ID: 11606855
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori cagA and vacA genes in dyspeptic Ghanaian patients.
Archampong TN; Asmah RH; Aidoo EK; Wiredu EK; Gyasi RK; Adjei DN; Beleza S; Bayliss CD; Krogfelt K
BMC Res Notes; 2017 Jun; 10(1):231. PubMed ID: 28655347
[TBL] [Abstract][Full Text] [Related]
53. Detection of H. pylori infection by ELISA and Western blot techniques and evaluation of anti CagA seropositivity in adult Turkish dyspeptic patients.
Yilmaz O; Sen N; Küpelioğlu AA; Simşek I
World J Gastroenterol; 2006 Sep; 12(33):5375-8. PubMed ID: 16981271
[TBL] [Abstract][Full Text] [Related]
54. Serologic response to lower-molecular-weight proteins of H. pylori is related to clinical outcome of H. pylori infection in Taiwan.
Shiesh SC; Sheu BS; Yang HB; Tsao HJ; Lin XZ
Dig Dis Sci; 2000 Apr; 45(4):781-8. PubMed ID: 10759250
[TBL] [Abstract][Full Text] [Related]
55. Clinical relevance of Helicobacter pylori CagA-positive strains: gastroduodenal peptic lesions marker.
Martín Guerrero JM; Hergueta Delgado P; Esteban Carretero J; Romero Castro R; Pellicer Bautista FJ; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2000 Mar; 92(3):160-73. PubMed ID: 10799946
[TBL] [Abstract][Full Text] [Related]
56. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection.
Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A
Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843
[TBL] [Abstract][Full Text] [Related]
57. CagA status and VacA subtypes of Helicobacter pylori in relation to histopathologic findings in Iranian population.
Molaei M; Foroughi F; Mashayekhi R; Haghazali M; Zojaji H; Jafari F; Dabiri H; Zali MR
Indian J Pathol Microbiol; 2010; 53(1):24-7. PubMed ID: 20090217
[TBL] [Abstract][Full Text] [Related]
58. Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy.
Heikkinen M; Janatuinen E; Mayo K; Mégraud F; Julkunen R; Pikkarainen P
Am J Gastroenterol; 1997 Dec; 92(12):2225-9. PubMed ID: 9399758
[TBL] [Abstract][Full Text] [Related]
59. H pylori infection among 1000 southern Iranian dyspeptic patients.
Hashemi MR; Rahnavardi M; Bikdeli B; Dehghani Zahedani M
World J Gastroenterol; 2006 Sep; 12(34):5479-82. PubMed ID: 17006984
[TBL] [Abstract][Full Text] [Related]
60. Relevance of underlying disease and bacterial vacA and cagA status on the efficacy of Helicobacter pylori eradication.
Rudi J; Reuther S; Sieg A; Hoerner M; Stremmel W
Digestion; 2002; 65(1):11-5. PubMed ID: 11961337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
